{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:01:03Z","timestamp":1793898063396,"version":"4.8.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The COVID-19 pandemic induced the rapid deployment of novel vaccines with pregnant persons identified as an at-risk population due to their increased risk of severe outcomes. Limited data on the immunogenicity of COVID-19 vaccines in pregnant persons were available at the time of implementation. To address this data gap, we developed a living systematic review summarizing emerging evidence on vaccine immunogenicity in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Following Cochrane, World Health Organization, and Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines, we included studies on COVID-19 vaccines during pregnancy. We carried out comprehensive biweekly literature searches from March 2022 to October 2023, covering multiple databases. Study selection, data extraction and risk of bias assessment were conducted by pairs of authors independently. Immunogenicity outcomes, primarily post-vaccination neutralizing or binding antibody concentrations, were analyzed descriptively. Post-vaccination antibody ratios in pregnant versus nonpregnant individuals were calculated for the subset of studies that included nonpregnant comparators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>By October 2023, our review encompassed 62 studies predominantly analyzing maternal sera (87%), with limited investigation regarding cord, neonatal and infant sera. Most studies investigated mRNA vaccines (97%) and focused on primary vaccination (82%), with some investigating booster doses (15%). Immunogenicity end points included spike-specific IgG (84%) and neutralizing antibodies (24%), with limited data on T-cell responses (3%). Antibodies were detectable after primary vaccination in most pregnant individuals, with similar or modestly attenuated concentrations compared to nonpregnant individuals (ratios &gt; 0.7 for 5\/6 estimates of spike-specific IgG), albeit with modest differences in antibody quality and kinetics. Long-term antibody-waning trajectories were similar between pregnant and nonpregnant individuals for up to 8 months after vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>mRNA COVID-19 vaccines induce a robust antibody response during pregnancy comparable (or modestly attenuated) relative to nonpregnant individuals. Immunogenicity data on non-mRNA vaccines are notably underrepresented in the existing literature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004633","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:01:48Z","timestamp":1739534508000},"page":"S27-S31","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-8040","authenticated-orcid":false,"given":"Jamile","family":"Ballivian","sequence":"first","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.K.","family":"Parker","sequence":"additional","affiliation":[{"name":"The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-5643","authenticated-orcid":false,"given":"Mabel","family":"Berrueta","sequence":"additional","affiliation":[{"name":"Department of Mother and Child Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-6122","authenticated-orcid":false,"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[{"name":"Argentine Cochrane Center, IECS, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-8933","authenticated-orcid":false,"given":"Fernando","family":"Argento","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-0073","authenticated-orcid":false,"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[{"name":"Centro de Investigaciones Epidemiol\u00f3gicas y Salud P\u00fablica (CIESP-IECS), Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-449X","authenticated-orcid":false,"given":"Martin","family":"Brizuela","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Castellana","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Comande","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-4709","authenticated-orcid":false,"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[{"name":"The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Charite Centre for Global Health, Charit\u00e9-Universit\u00e4tsmedizin, Vaccine Centre, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-2705","authenticated-orcid":false,"given":"Agustina","family":"Mazzoni","sequence":"additional","affiliation":[{"name":"Department of Mother and Child Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-2469","authenticated-orcid":false,"given":"Juan M.","family":"Sambade","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3427-0630","authenticated-orcid":false,"given":"Katharina","family":"Stegelmann","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-5059","authenticated-orcid":false,"given":"Xu","family":"Xiong","sequence":"additional","affiliation":[{"name":"Tulane University, Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-7689","authenticated-orcid":false,"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-6627","authenticated-orcid":false,"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[{"name":"University of Washington, Schools of Pharmacy and Public Health, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4294-8559","authenticated-orcid":false,"given":"Pierre","family":"Buekens","sequence":"additional","affiliation":[{"name":"Tulane University, Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1016\/S2214-109X(21)00043-7","article-title":"An interactive website tracking COVID-19 vaccine development.","volume":"9","author":"Shrotri","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"e0253974","DOI":"10.1371\/journal.pone.0253974","article-title":"COVID-19 and pregnancy: an umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes.","volume":"16","author":"Ciapponi","year":"2021","journal-title":"PLoS One"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1038\/s41598-021-92357-y","article-title":"Maternal outcomes and risk factors for COVID-19 severity among pregnant women.","volume":"11","author":"Vouga","year":"2021","journal-title":"Sci Rep"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"e32954","DOI":"10.1097\/MD.0000000000032954","article-title":"Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: a protocol for systematic review and meta analysis.","volume":"102","author":"Ciapponi","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.vaccine.2024.02.012","article-title":"Safe in pregnancy: a global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.","volume":"42","author":"Buekens","year":"2024","journal-title":"Vaccine"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial.","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults.","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"R9-20260413"},{"key":"R11-20260413","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40264-024-01458-w","article-title":"Safety and effectiveness of COVID-19 vaccines during pregnancy: a living systematic review and meta-analysis.","volume":"47","author":"Ciapponi","year":"2024","journal-title":"Drug Saf"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/uog.23729","article-title":"Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.","volume":"58","author":"Bookstein Peretz","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20260413","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2022.07.014","article-title":"COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.","volume":"228","author":"Atyeo","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"ofad204","DOI":"10.1093\/ofid\/ofad204","article-title":"Neutralizing antibody responses to messenger RNA coronavirus disease 2019 vaccines versus severe acute respiratory syndrome coronavirus 2 infection among pregnant women and vaccine-induced antibody transfer to infants.","volume":"10","author":"Dawood","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/v14020307","article-title":"Immunogenicity following administration of BNT162b2 and Ad26.COV2.S COVID-19 vaccines in the pregnant population during the third trimester.","volume":"14","author":"Citu","year":"2022","journal-title":"Viruses"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women.","volume":"325","author":"Collier","year":"2021","journal-title":"JAMA"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/uog.26050","article-title":"Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.","volume":"60","author":"Blakeway","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"100796","DOI":"10.1016\/j.ajogmf.2022.100796","article-title":"Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.","volume":"5","author":"Prabhu","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R20-20260413","doi-asserted-by":"crossref","first-page":"eabi8631","DOI":"10.1126\/scitranslmed.abi8631","article-title":"COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women.","volume":"13","author":"Atyeo","year":"2021","journal-title":"Sci Transl Med"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2015.00289","article-title":"Immunogenicity and clinical efficacy of influenza vaccination in pregnancy.","volume":"6","author":"Kay","year":"2015","journal-title":"Front Immunol"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"4857872","DOI":"10.1155\/2022\/4857872","article-title":"Safety and immunogenicity of pertussis vaccine immunization during pregnancy: a meta-analysis of randomized clinical trials.","volume":"2022","author":"Simayi","year":"2022","journal-title":"J Trop Med"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/infdis\/jis592","article-title":"Pregnancy modifies the antibody response to trivalent influenza immunization.","volume":"206","author":"Schlaudecker","year":"2012","journal-title":"J Infect Dis"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/jiv138","article-title":"Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine.","volume":"212","author":"Kay","year":"2015","journal-title":"J Infect Dis"},{"key":"R25-20260413","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijid.2023.02.022","article-title":"Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.","volume":"130","author":"Zilver","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R26-20260413","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms.","volume":"13","author":"Atyeo","year":"2022","journal-title":"Nat Commun"},{"key":"R27-20260413","doi-asserted-by":"crossref","first-page":"e150319","DOI":"10.1172\/JCI150319","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.","volume":"131","author":"Beharier","year":"2021","journal-title":"J Clin Invest"},{"key":"R28-20260413","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14014","article-title":"The association of maternal SARS-CoV-2 vaccination-to-delivery interval and the levels of maternal and cord blood antibodies.","volume":"156","author":"Ben-Mayor Bashi","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"R29-20260413","doi-asserted-by":"crossref","first-page":"e2240993","DOI":"10.1001\/jamanetworkopen.2022.40993","article-title":"Comparison of maternal and neonatal antibody levels after COVID-19 vaccination vs SARS-CoV-2 infection.","volume":"5","author":"Flannery","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R30-20260413","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP).","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis.","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:02:06Z","timestamp":1776088926000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004633","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}